PAR
Click for more information
2.17% 23.5¢ paradigm biopharmaceuticals limited..

Haha yes, but it's a blinded trial so no-one (including the...

  1. MisterMister
    572 Posts.
    lightbulb Created with Sketch. 55
    clock Created with Sketch.
    26/10/21
    13:06
    Post #: 57078724
    Haha yes, but it's a blinded trial so no-one (including the physician) should know if the patient got the active or not. Makes sense or is investing in biotech purely a blind punt for you?
    PAR Price at posting: $1.94 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢ 		Change
0.005(2.17%) 		Mkt cap ! $83.95M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $138.4K 588.0K

Buyers (Bids)

No. Vol. Price($)
3 26062 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 27172 7
View Market Depth
Last trade - 14.25pm 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.